A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...
Medpage Today on MSN16d
Stent-Like Hybrid on Track for Lofty Long-Term Goals in PCITCT discussant Joanna Wykrzykowska, MD, PhD, of University Medical Center Groningen in the Netherlands, said she was "very ...
To understand the global market potential, growth, and scope, the market is segmented based on product type (drug-eluting ...
Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior ...
You’ll usually need to continue dual antiplatelet drug therapy for a year after a drug-eluting stent placement and a month after a bare-metal stent placement. Drug-eluting stents are a newer ...
Hello Health Rounds Readers! Today we have three studies presented at medical meetings, including one testing a device that ...
For patients with severely calcified coronary lesions, routine treatment with orbital atherectomy prior to drug-eluting stent ...
There's been little doctors can do to help patients in this situation, but a newly developed 'hourglass' stent may be a novel ...
The Espirit everolimus-eluting scaffold. [Image from the Abbott website] Abbott (NYSE:ABT) today announced data demonstrating ...
It is an advanced dual-drug polymer-free coated stent (DDCS). A significant development in drug-eluting stent technology, ...
Un cœur qui bat plus fort. Le 10 octobre, le centre hospitalier de Valenciennes a été le second hôpital des Hauts-de-France a réalisé l’implantation d’un stent résorbable, sur un patient de 44 ans.
One of the presenters of BBC's Springwatch last year announced they'd had a heart attack after having a stent fitted, however ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback